Stockscreener 앱 받기
4.38
9.23%
0.37
시간 외 거래:
4.69
0.31
+7.08%
Onkure Therapeutics Inc 주식(OKUR)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Published on: 2026-03-19 04:03:55 - baoquankhu1.vn
OnKure reports nearly $60M cash on hand as drug trials continue - BizWest
HC Wainwright Has Positive Forecast for OKUR Q1 Earnings - MarketBeat
OnKure Therapeutics (NASDAQ:OKUR) Price Target Lowered to $27.00 at HC Wainwright - Defense World
OnKure Therapeutics (OKUR): HC Wainwright & Co. Adjusts Price Ta - GuruFocus
H.C. Wainwright cuts OnKure stock price target to $27 on funding - Investing.com
Wall Street Zen Upgrades OnKure Therapeutics (NASDAQ:OKUR) to Hold - Defense World
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - Sahm
OnKure Therapeutics, Inc. 2025 Annual Report: Precision Oncology Pipeline and Focus on PI3Kα Inhibitors - Minichart
Onkure Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Breast cancer trial data and $59M cash: inside OnKure's 2026 pipeline plans - Stock Titan
Can OnKure Therapeutics Inc deliver consistent EPS growth2025 Market Trends & Accurate Intraday Trading Signals - baoquankhu1.vn
Onkure Therapeutics Inc expected to post a loss of $1.15 a shareEarnings Preview - TradingView
OKUR PE Ratio & Valuation, Is OKUR Overvalued - Intellectia AI
Pullback Watch: What is the PEG ratio of OnKure Therapeutics IncJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - baoquankhu1.vn
Why OnKure Therapeutics Inc. stock appeals to dividend seekersWeekly Investment Recap & Expert Approved Trade Ideas - mfd.ru
[SCHEDULE 13G] OnKure Therapeutics, Inc. Passive Investment Disclosure (>5%) - Stock Titan
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Up 43.6% in January - Defense World
Is OnKure Therapeutics Inc. stock oversold or undervaluedJuly 2025 Rallies & Community Trade Idea Sharing Platform - mfd.ru
EV Market: Should I set a stop loss on OnKure Therapeutics Inc2025 Risk Factors & Reliable Price Breakout Signals - baoquankhu1.vn
Is OnKure Therapeutics Inc. in a bullish channelJuly 2025 Technicals & Technical Entry and Exit Tips - mfd.ru
Top Entero Therapeutics (GRDX) Competitors 2026 - MarketBeat
Published on: 2026-01-29 15:39:37 - mfd.ru
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), OnKure Therapeutics (OKUR) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Why OnKure Therapeutics Inc. stock could be next big winnerShort Interest Overview & High Yield Trading Alerts - bollywoodhelpline.com
Analyzing Nautilus Biotechnology (NASDAQ:NAUT) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Receives Average Rating of “Hold” from Analysts - Defense World
Published on: 2026-01-11 10:53:08 - Улправда
Targets Report: How risky is OnKure Therapeutics Inc stock nowEarnings Recap Summary & Weekly Sector Rotation Insights - Bộ Nội Vụ
How OnKure Therapeutics Inc. stock performs in weak economyEarnings Overview Report & Daily Market Momentum Tracking - Улправда
Geopolitics Watch: How risky is OnKure Therapeutics Inc. stock nowMarket Sentiment Review & Detailed Earnings Play Strategies - Улправда
Bear Alert: Will OnKure Therapeutics Inc stock attract ESG investorsFed Meeting & Weekly High Momentum Picks - Bộ Nội Vụ
Rally Mode: Why OnKure Therapeutics Inc. stock could be next big winnerJuly 2025 Snapshot & Safe Entry Trade Reports - Улправда
How OnKure Therapeutics Inc. stock performs after earnings - ulpravda.ru
What hedge fund activity signals for OnKure Therapeutics Inc. stock2026 world cup usa national team quarterfinals key players high defensive line odds analysis insights - ulpravda.ru
Will OnKure Therapeutics Inc. stock attract more institutional investors2026 world cup usa national team third place match playmakers high defensive line expert forecast expert opinion - ulpravda.ru
Quarterly Recap: How British Land Company PLC BLD stock expands through international marketsFed Meeting & AI Forecasted Entry and Exit Points - moha.gov.vn
Bull Bear: Why OnKure Therapeutics Inc stock is a must watch in 2025Weekly Profit Report & Low Risk Entry Point Tips - moha.gov.vn
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Up 25.6% in December - Defense World
OnKure Therapeutics CEO Saccomano sells $258 in stock By Investing.com - Investing.com India
OnKure Therapeutics Inc Stock Analysis and ForecastDay Trading Setups & Identify Winning Stocks - earlytimes.in
OnKure Therapeutics CFO Leverone sells $896 in stock By Investing.com - Investing.com Canada
OnKure Therapeutics CFO Leverone sells $896 in stock - Investing.com
OnKure Therapeutics CEO Saccomano sells $258 in stock - Investing.com
Is OnKure Therapeutics Inc. stock a safe investment in uncertain markets2025 Geopolitical Influence & AI Based Trade Execution Alerts - Улправда
Aug Technicals: What analyst consensus says on UYSCU stockJuly 2025 Macro Moves & Safe Entry Trade Reports - moha.gov.vn
Can OnKure Therapeutics Inc. stock sustain free cash flow growthWeekly Stock Recap & Precise Swing Trade Alerts - Улправда
Can OnKure Therapeutics Inc. stock rebound after recent weaknessWeekly Market Outlook & Free Community Consensus Stock Picks - Улправда
Why OnKure Therapeutics Inc. stock could rally in 2025Wall Street Watch & Weekly High Conviction Trade Ideas - Bölüm Sonu Canavarı
Why OnKure Therapeutics Inc. stock is considered a top pick2025 Market Trends & Free Expert Verified Stock Movement Alerts - Улправда
1.20%
0.06%
자본화:
|
볼륨(24시간):